These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients. Menon DV; Arbique D; Wang Z; Adams-Huet B; Auchus RJ; Vongpatanasin W J Clin Endocrinol Metab; 2009 Apr; 94(4):1361-6. PubMed ID: 19158191 [TBL] [Abstract][Full Text] [Related]
3. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722 [No Abstract] [Full Text] [Related]
4. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone. Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012 [TBL] [Abstract][Full Text] [Related]
5. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]. Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983 [TBL] [Abstract][Full Text] [Related]
6. Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress. Yamanari H; Nakamura K; Miura D; Yamanari S; Ohe T Clin Exp Hypertens; 2009 Oct; 31(7):585-94. PubMed ID: 19886856 [TBL] [Abstract][Full Text] [Related]
7. [Hypertension--diuretics as antihypertensive agents]. Ikeda T Nihon Rinsho; 1970 Apr; 28(4):1266-71. PubMed ID: 4913896 [No Abstract] [Full Text] [Related]
8. Serum cholesterol during treatment of hypertension with diuretic drugs. Ames RP; Peacock PB Arch Intern Med; 1984 Apr; 144(4):710-4. PubMed ID: 6712367 [TBL] [Abstract][Full Text] [Related]
9. [Spironolactone combined with chlorthalidone in the treatment of essential arterial hypertension]. Gragnoli G; Puccetti F; Tanganelli I; Favilli R; Nami R Minerva Med; 1975 Apr; 66(30):1412-6. PubMed ID: 1143685 [TBL] [Abstract][Full Text] [Related]
10. [Antihypertensive effects of clonidine and of the clonidine-chlorthalidone combination]. D'Amelio G; Dalla Volta S; De Longhi B; Razzolini R Minerva Med; 1974 May; 65(41):2342-9. PubMed ID: 4602117 [No Abstract] [Full Text] [Related]
11. Spironolactone management of resistant hypertension. Marrs JC Ann Pharmacother; 2010 Nov; 44(11):1762-9. PubMed ID: 20978214 [TBL] [Abstract][Full Text] [Related]
12. [All diuretics used in the treatment of hypertension are not the same]. Asil S; Atalar E Turk Kardiyol Dern Ars; 2017 Jan; 45(1):94-101. PubMed ID: 28106027 [TBL] [Abstract][Full Text] [Related]
13. Chlorthalidone versus hydrochlorothiazide as the preferred diuretic: is there a verdict yet? Flack JM; Sica DA; Nesbitt S Hypertension; 2011 Apr; 57(4):665-6. PubMed ID: 21383308 [No Abstract] [Full Text] [Related]
14. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial. Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421 [TBL] [Abstract][Full Text] [Related]
15. [A comparative study of spironolactone and chlorthalidone in treatment of hypertension]. Fagerberg SE; Göransson K Lakartidningen; 1974 Jan; 71(3):175-7. PubMed ID: 4837216 [No Abstract] [Full Text] [Related]
16. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis. Roush GC; Abdelfattah R; Song S; Ernst ME; Sica DA; Kostis JB J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1507-1515. PubMed ID: 30251403 [TBL] [Abstract][Full Text] [Related]
17. Spironolactone and doxazosin treatment in patients with resistant hypertension. Rodilla E; Costa JA; Pérez-Lahiguera F; Baldó E; González C; Pascual JM Rev Esp Cardiol; 2009 Feb; 62(2):158-66. PubMed ID: 19232189 [TBL] [Abstract][Full Text] [Related]
19. The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease. Georgianos PI; Vaios V; Kontogiorgos I; Divani M; Liakopoulos V Expert Rev Clin Pharmacol; 2024; 17(5-6):415-418. PubMed ID: 38511397 [No Abstract] [Full Text] [Related]
20. Prolonged treatment with clonidine: comparative antihypertensive effects alone and with a diuretic agent. Mroczek WJ; Davidov M; Finnerty FA Am J Cardiol; 1972 Oct; 30(5):536-41. PubMed ID: 5073666 [No Abstract] [Full Text] [Related] [Next] [New Search]